Literature DB >> 25105252

Functional role of TGF-β receptors during palatal fusion in vitro.

Akira Nakajima1, Yoshihiro Ito2, Eiji Tanaka3, Remi Sano4, Yoko Karasawa4, Masao Maeno5, Koichi Iwata5, Noriyoshi Shimizu6, Charles F Shuler7.   

Abstract

OBJECTIVE: Reported expression patterns for TGF-β receptors (TβR-I, -II, and -III) during palatogenesis suggest that they play essential roles in the mechanisms leading to palatal fusion. The purpose of this study was to compare the functions of the three TβRs during palatal fusion.
METHODS: Using organ culture of mouse palatal shelves, expression levels of TβR-I, -II, and -III were suppressed by transfecting the siRNAs siTβR-I, -II, and -III, respectively. Phosphorylation of SMAD2 was examined as an indicator of downstream signalling via each TβR. Linkage between TGF-β signalling and critical events in palatal fusion led to the use of, MMP-13 expression as an outcome measure for the function of the TGF-β receptors.
RESULTS: The siRNA treatment decreased the expression level of each receptor by more than 85%. When treated with either siTβR-I or -II, palatal shelves at E13+72 h were not fused, with complete clefting in the anterior and posterior regions. The middle palatal region following treatment with either siTβR-I or -II had fusion from one-half or one-third of the palatal region. Treatment with siTβR-III resulted in a persistent midline seam of medial edge epithelium (MEE) in the anterior region with islands of persistent MEE in the middle and posterior regions of the midline. Treatment with all three siTβRs altered the pattern of SMAD2 phosphorylation. Palatal shelf cultures treated with siTβR-I or -II, but not -III, showed altered MMP-13 expression levels.
CONCLUSION: The ability to identify and recover MEE and palatal mesenchymal cells during palatal fusion will aid in the evaluation of the different mechanistic events regulated by each TβR during palatogenesis.
Copyright © 2014 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  MMP-13 expression; Palatal development; SMAD2 phosphorylation; TGF-β receptor; TGF-β signalling; siRNA

Mesh:

Substances:

Year:  2014        PMID: 25105252      PMCID: PMC4152943          DOI: 10.1016/j.archoralbio.2014.07.007

Source DB:  PubMed          Journal:  Arch Oral Biol        ISSN: 0003-9969            Impact factor:   2.633


  46 in total

1.  Ligand binding and functional properties of betaglycan, a co-receptor of the transforming growth factor-beta superfamily. Specialized binding regions for transforming growth factor-beta and inhibin A.

Authors:  J Esparza-Lopez; J L Montiel; M M Vilchis-Landeros; T Okadome; K Miyazono; F López-Casillas
Journal:  J Biol Chem       Date:  2001-02-05       Impact factor: 5.157

2.  TGF-beta3-induced palatogenesis requires matrix metalloproteinases.

Authors:  L Blavier; A Lazaryev; J Groffen; N Heisterkamp; Y A DeClerck; V Kaartinen
Journal:  Mol Biol Cell       Date:  2001-05       Impact factor: 4.138

Review 3.  Mechanisms of TGF-beta signaling from cell membrane to the nucleus.

Authors:  Yigong Shi; Joan Massagué
Journal:  Cell       Date:  2003-06-13       Impact factor: 41.582

4.  Type III TGF-beta receptor-independent signalling of TGF-beta2 via TbetaRII-B, an alternatively spliced TGF-beta type II receptor.

Authors:  D Rotzer; M Roth; M Lutz; D Lindemann; W Sebald; P Knaus
Journal:  EMBO J       Date:  2001-02-01       Impact factor: 11.598

5.  TGF-β-activated kinase 1 (Tak1) mediates agonist-induced Smad activation and linker region phosphorylation in embryonic craniofacial neural crest-derived cells.

Authors:  Kenji Yumoto; Penny S Thomas; Jamie Lane; Kouichi Matsuzaki; Maiko Inagaki; Jun Ninomiya-Tsuji; Gregory J Scott; Manas K Ray; Mamoru Ishii; Robert Maxson; Yuji Mishina; Vesa Kaartinen
Journal:  J Biol Chem       Date:  2013-04-01       Impact factor: 5.157

6.  Temporospatial distribution of matrix metalloproteinase and tissue inhibitors of matrix metalloproteinases during murine secondary palate morphogenesis.

Authors:  J Morris-Wiman; H Burch; E Basco
Journal:  Anat Embryol (Berl)       Date:  2000-08

7.  Medial edge epithelial cell fate during palatal fusion.

Authors:  C Martínez-Alvarez; C Tudela; J Pérez-Miguelsanz; S O'Kane; J Puerta; M W Ferguson
Journal:  Dev Biol       Date:  2000-04-15       Impact factor: 3.582

8.  Abnormal angiogenesis but intact hematopoietic potential in TGF-beta type I receptor-deficient mice.

Authors:  J Larsson; M J Goumans; L J Sjöstrand; M A van Rooijen; D Ward; P Levéen; X Xu; P ten Dijke; C L Mummery; S Karlsson
Journal:  EMBO J       Date:  2001-04-02       Impact factor: 11.598

9.  Heart and liver defects and reduced transforming growth factor beta2 sensitivity in transforming growth factor beta type III receptor-deficient embryos.

Authors:  Kaye L Stenvers; Melinda L Tursky; Kenneth W Harder; Nicole Kountouri; Supavadee Amatayakul-Chantler; Dianne Grail; Clayton Small; Robert A Weinberg; Andrew M Sizeland; Hong-Jian Zhu
Journal:  Mol Cell Biol       Date:  2003-06       Impact factor: 4.272

10.  TGF-beta3-dependent SMAD2 phosphorylation and inhibition of MEE proliferation during palatal fusion.

Authors:  Xiao-Mei Cui; Yang Chai; Jucheng Chen; Tadashi Yamamoto; Yoshihiro Ito; Pablo Bringas; Charles F Shuler
Journal:  Dev Dyn       Date:  2003-07       Impact factor: 3.780

View more
  3 in total

1.  Identification of Smad-dependent and -independent signaling with transforming growth factor-β type 1/2 receptor inhibition in palatogenesis.

Authors:  Yoshimi Suzuki; Akira Nakajima; Takayuki Kawato; Koichi Iwata; Mitsuru Motoyoshi; Charles F Shuler
Journal:  J Oral Biol Craniofac Res       Date:  2020-01-16

2.  Nicotine Exposure During Pregnancy Results in Persistent Midline Epithelial Seam With Improper Palatal Fusion.

Authors:  Ferhat Ozturk; Elizabeth Sheldon; Janki Sharma; Kemal Murat Canturk; Hasan H Otu; Ali Nawshad
Journal:  Nicotine Tob Res       Date:  2015-10-06       Impact factor: 4.244

Review 3.  TGF-β Signaling and the Epithelial-Mesenchymal Transition during Palatal Fusion.

Authors:  Akira Nakajima; Charles F Shuler; Alexander O D Gulka; Jun-Ichi Hanai
Journal:  Int J Mol Sci       Date:  2018-11-19       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.